TrialPanorama/TrialPanorama-database huggingface dataset:
Study 33066009 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33066009 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33216632 — Surrogate Endpoint (SUR): Blood pressure
Study 33216632 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study 34057279 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 35294320 — Predictive Biomarker (PRD): PPT1 mRNA
Genes: PPT1; CLN1; PPT
Study 32471514 — Predictive Biomarker (PRD): PIP mRNA
Genes: PIP; GCDFP15; GPIP4
Study 616063492 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 36018753 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 36018753 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 33290616 — Predictive Biomarker (PRD): TYK2 mRNA
Genes: TYK2
Study 616269767 — Surrogate Endpoint (SUR): Blood pressure
Study 32962487 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 32746749 — Surrogate Endpoint (SUR): Blood pressure
Study 32746749 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 34416788 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 34416788 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 35951113 — Safety Biomarker (SAF): DRD2
Study 33591858 — Predictive Biomarker (PRD): NANOS3 mRNA
Genes: NANOS3; NOS3
Study 33591858 — Surrogate Endpoint (SUR): Blood pressure
Study 32836016 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Neurofilament light polypeptide
Genes: NEFL; NF68; NFL
Study 35234673 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Angiopoietin-2
Genes: ANGPT2
Study 36198470 — Predictive Biomarker (PRD): MFSD11 mRNA
Genes: MFSD11; ET
Study 36434768 — Predictive Biomarker (PRD): LIPA mRNA
Genes: LIPA
Study 35010877 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 35010877 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study 35010877 — Safety Biomarker (SAF): BDNF
Study 36174817 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study 34289889 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 32668833 — Surrogate Endpoint (SUR): Forced vital capacity
Study 36166132 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 36166132 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 36166132 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 36007566 — Predictive Biomarker (PRD): KLHL17 mRNA
Genes: KLHL17; AF
Study 36007566 — Surrogate Endpoint (SUR): Blood pressure
Study 33693907 — Surrogate Endpoint (SUR): Bone mineral density
Study 32916306 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study 32916306 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC6A4 mRNA
Genes: SLC6A4; HTT; SERT
Study 34649825 — Surrogate Endpoint (SUR): Blood pressure
Study 35071600 — Predictive Biomarker (PRD): ROS1
Genes: MCF3; ROS; c-ros-1
Study 35071600 — Safety Biomarker (SAF): Reactive oxygen species
Study 35071600 — Surrogate Endpoint (SUR): Blood pressure
Study 35946246 — Surrogate Endpoint (SUR): Blood pressure
Study 36174627 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 36114020 — Predictive Biomarker (PRD): LMNA mRNA
Genes: LMNA; LMN1
Study 36114020 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 36254014 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32612085 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 32612085 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 35487860 — Surrogate Endpoint (SUR): Blood pressure
Study 35459599 — Predictive Biomarker (PRD): SP6 mRNA
Genes: SP6; KLF14
Study 35459599 — Predictive Biomarker (PRD): PCSK5 mRNA
Genes: PCSK5; PC5; PC6
Study 35316429 — Predictive Biomarker (PRD): CGA mRNA
Genes: CGA
Study 32306100 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study 33705531 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33252075 — Pharmacodynamic Biomarker (PDY): Beta-secretase 1
Genes: BACE1; BACE; KIAA1149
Study 32054483 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 32054483 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32054483 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study 32054483 — Safety Biomarker (SAF): Hyaluronic acid
Study 33392835 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33392835 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33392835 — Predictive Biomarker (PRD): Hormone receptor
Study 35120505 — Predictive Biomarker (PRD): FBXO8 mRNA
Genes: FBXO8; FBS; FBX8; DC10; UNQ1877/PRO4320
Study 33754809 — Surrogate Endpoint (SUR): Serum creatinine
Study 36078441 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study 33147123 — Predictive Biomarker (PRD): TUB mRNA
Genes: TUB
Study 32239659 — Surrogate Endpoint (SUR): Blood pressure
Study 34469767 — Surrogate Endpoint (SUR): Blood pressure
Study 32362238 — Predictive Biomarker (PRD): DAP mRNA
Genes: DAP; DAP1
Study 33545945 — Predictive Biomarker (PRD): ST18 mRNA
Genes: ST18; KIAA0535; ZNF387
Study 32278783 — Predictive Biomarker (PRD): Zinc finger protein GLI1
Genes: GLI1; GLI
Study 33804374 — Surrogate Endpoint (SUR): Forced vital capacity
Study 35599913 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35599913 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 35599913 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 35599913 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32330277 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33011207 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 32563253 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 35337314 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 36343646 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study 34294784 — Surrogate Endpoint (SUR): Blood pressure
Study 34008811 — Surrogate Endpoint (SUR): Blood pressure
Study 32729657 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 616063504 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 616063504 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 616063504 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 616063504 — Monitoring Biomarker (MOI): IL4 mRNA
Genes: IL4
Study 616063504 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 616063504 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 616063504 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 34981344 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 34981344 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 32647911 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 36122588 — Surrogate Endpoint (SUR): Serum uric acid
Study 34224994 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 32245746 — Surrogate Endpoint (SUR): Blood pressure
Study 34482505 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34482505 — Safety Biomarker (SAF): Reactive oxygen species
Study 34226226 — Surrogate Endpoint (SUR): Blood pressure
Study 34348606 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 33320779 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 36114653 — Predictive Biomarker (PRD): TNFSF10 mRNA
Genes: TNFSF10; APO2L; TRAIL
Study 36114653 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 36114653 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 32993754 — Pharmacodynamic Biomarker (PDY): Mismatch negativity
Study 36120427 — Predictive Biomarker (PRD): DICER1 mRNA
Genes: DICER1; DICER; HERNA; KIAA0928
Study 36120427 — Predictive Biomarker (PRD): YBX1 mRNA
Genes: YBX1; NSEP1; YB1
Study 36120427 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-20a
Genes: MIR20A
Study 36120427 — Monitoring Biomarker (MOI): miR-92a-3p
Study 36120427 — Monitoring Biomarker (MOI): miR-195-5p
Genes: MIR195
Study 34148051 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 32785986 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study 33568383 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35419530 — Predictive Biomarker (PRD): MEST mRNA
Genes: MEST; PEG1
Study 36271847 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 34052828 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study 36136861 — Predictive Biomarker (PRD): NNT mRNA
Genes: NNT
Study 34999239 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35152573 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 36308070 — Predictive Biomarker (PRD): C1QC mRNA
Genes: C1QC; C1QG
Study 33059356 — Safety Biomarker (SAF): BDNF
Study 33059356 — Surrogate Endpoint (SUR): Blood pressure
Study 33188930 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35537533 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 32317794 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 32514076 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 32514076 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32514076 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 35986699 — Predictive Biomarker (PRD): TYK2 mRNA
Genes: TYK2
Study 35986699 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study 32404117 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 32465073 — Predictive Biomarker (PRD): EVL mRNA
Genes: EVL; RNB6
Study 34480880 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35338847 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 34142339 — Surrogate Endpoint (SUR): Blood pressure
Study 34075813 — Surrogate Endpoint (SUR): Serum creatinine
Study 36147791 — Predictive Biomarker (PRD): AWAT2 mRNA
Genes: AWAT2; DC4; DGAT2L4; MFAT; WS
Study 32208040 — Predictive Biomarker (PRD): KIT
Genes: CD117; SCFR; C-Kit
Study 32208040 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 34645649 — Pharmacodynamic Biomarker (PDY): Retinoblastoma-associated protein
Genes: RB1
Study 34645649 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): CCNE1 mRNA
Genes: CCNE1; CCNE
Study 34645649 — Predictive Biomarker (PRD): CCND1 mRNA
Genes: CCND1; BCL1; PRAD1
Study 34645649 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 33169920 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study 34977544 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study 34977544 — Predictive Biomarker (PRD): MAL mRNA
Genes: MAL
Study 33430695 — Predictive Biomarker (PRD): ABCC8 mRNA
Genes: ABCC8; HRINS; SUR; SUR1
Study 35654589 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 33420265 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 33420265 — Predictive Biomarker (PRD): NAAA mRNA
Genes: NAAA; ASAHL; PLT
Study 33420265 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study 33420265 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 33420265 — Surrogate Endpoint (SUR): Serum creatinine
Study 33035140 — Surrogate Endpoint (SUR): Serum testosterone
Study 32436638 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 35113042 — Predictive Biomarker (PRD): ABR mRNA
Genes: ABR
Study 35837981 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 34903983 — Surrogate Endpoint (SUR): Blood pressure
Study 34903983 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study 32997242 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 34246603 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 32964140 — Surrogate Endpoint (SUR): Blood pressure
Study 35210767 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32188326 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 32188326 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 32779011 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 34868084 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study 34868084 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 36159262 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33619171 — Predictive Biomarker (PRD): CD276 mRNA
Genes: CD276; B7H3; PSEC0249; UNQ309/PRO352
Study 35780241 — Predictive Biomarker (PRD): SMS mRNA
Genes: SMS
Study 34301734 — Surrogate Endpoint (SUR): Blood pressure
Study 34853062 — Surrogate Endpoint (SUR): Serum creatinine
Study 35503345 — Surrogate Endpoint (SUR): Blood pressure
Study 36362743 — Predictive Biomarker (PRD): C2 mRNA
Genes: C2
Study 36362743 — Monitoring Biomarker (MOI): Complement C7
Genes: C7
Study 32967646 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32882101 — Surrogate Endpoint (SUR): Blood pressure
Study 32479187 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 32479187 — Predictive Biomarker (PRD): Hormone receptor
Study 35022282 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 35022282 — Safety Biomarker (SAF): C-X-C motif chemokine 5
Genes: CXCL5; ENA78; SCYB5
Study 35022282 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): FasL mRNA
Genes: FASLG; APT1LG1; CD95L; FASL; TNFSF6
Study 35022282 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 34069117 — Predictive Biomarker (PRD): LTA mRNA
Genes: LTA; TNFB; TNFSF1
Study 32173886 — Safety Biomarker (SAF): Cytochrome c
Study 33227833 — Surrogate Endpoint (SUR): Probing pocket depth
Study 35589610 — Predictive Biomarker (PRD): CXCR1 mRNA
Genes: CXCR1; CMKAR1; IL8RA
Study 35589610 — Predictive Biomarker (PRD): CXCR2 mRNA
Genes: CXCR2; IL8RB
Study 35589610 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 33130034 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 33130034 — Safety Biomarker (SAF): BDNF
Study 33130034 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 32065861 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 33942327 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34859493 — Surrogate Endpoint (SUR): Blood pressure
Study 32391667 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34869172 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 36096824 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34485157 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 34485157 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 32473084 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study 33719918 — Surrogate Endpoint (SUR): Bone mineral density
Study 33150360 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 35864751 — Predictive Biomarker (PRD): PICALM mRNA
Genes: PICALM; CALM
Study 35864751 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 35864751 — Predictive Biomarker (PRD): NRG1 mRNA
Genes: NRG1; GGF; HGL; HRGA; NDF; SMDF
Study 35864751 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 32299454 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 36027559 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 32443298 — Safety Biomarker (SAF): Interleukin 1
Study 35232229 — Predictive Biomarker (PRD): SP6 mRNA
Genes: SP6; KLF14
Study 34628881 — Surrogate Endpoint (SUR): Blood pressure
Study 33497465 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 32572779 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 32572779 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC2A4 mRNA
Genes: SLC2A4; GLUT4
Study 35538143 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study 35538143 — Surrogate Endpoint (SUR): Pathological complete response
Study 32178279 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 35398293 — Surrogate Endpoint (SUR): Bone mineral density
Study 33577729 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 34173699 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 35691596 — Predictive Biomarker (PRD): TACR3 mRNA
Genes: TACR3; NK3R; TAC3R
Study 34215870 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35947817 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study 36382669 — Predictive Biomarker (PRD): TRPV1 mRNA
Genes: TRPV1; VR1
Study 35356610 — Predictive Biomarker (PRD): NPY mRNA
Genes: NPY
Study 36127497 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 33492733 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 33492733 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33492733 — Predictive Biomarker (PRD): A2M mRNA
Genes: A2M; CPAMD5; FWP007
Study 33492733 — Safety Biomarker (SAF): IL-6 and IL-10
Study 34931289 — Surrogate Endpoint (SUR): Serum creatinine
Study 34931289 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study 32873686 — Surrogate Endpoint (SUR): Blood pressure
Study 34467593 — Predictive Biomarker (PRD): NR1H4 mRNA
Genes: NR1H4; BAR; FXR; HRR1; RIP14
Study 34467593 — Monitoring Biomarker (MOI): HBV DNA
Study 32785911 — Surrogate Endpoint (SUR): Blood pressure
Study 34231332 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 32544561 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 32544561 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 32310911 — Predictive Biomarker (PRD): EPX mRNA
Genes: EPX; EPER; EPO; EPP
Study 32310911 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34521963 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 32663980 — Safety Biomarker (SAF): miR-9
Study 32522095 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35108610 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study 34398083 — Safety Biomarker (SAF): Hyaluronic acid
Study 32156788 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 34919073 — Surrogate Endpoint (SUR): Bone mineral density
Study 36069950 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 34256810 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 32013568 — Surrogate Endpoint (SUR): Bone mineral density
Study 32013568 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 35395866 — Predictive Biomarker (PRD): SHANK3 mRNA
Genes: SHANK3; KIAA1650; PROSAP2; PSAP2
Study 35073968 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34602419 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 36183143 — Predictive Biomarker (PRD): ABCA3 mRNA
Genes: ABCA3; ABC3
Study 36183143 — Predictive Biomarker (PRD): DCC mRNA
Genes: DCC; IGDCC1
Study 34082710 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 32188702 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study 33983395 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study 36297065 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study 32475458 — Safety Biomarker (SAF): Reactive oxygen species
Study 32475458 — Safety Biomarker (SAF): Cytochrome c
Study 32475458 — Predictive Biomarker (PRD): CASP9
Genes: MCH6; ICE-LAP6; APAF-3; PPP1R56
Study 32475458 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32475458 — Safety Biomarker (SAF): IL-6 and IL-10
Study 33358119 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33905304 — Surrogate Endpoint (SUR): Blood pressure
Study 34473043 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 34473043 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 33919631 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study 33904666 — Predictive Biomarker (PRD): POR mRNA
Genes: POR; CYPOR
Study 33904666 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 32512248 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32241619 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB